GenSight Biologics SA Sustainability Reports

GenSight Biologics S.A. is a clinical-stage biotechnology company that discovers and develops novel gene therapies for neurodegenerative retinal diseases and central nervous system disorders.

Sector: Professional & technical services

Country: France

Exchange: Euronext Paris

ISIN: FR0013183985

11 reports from 2015 to 2025

• GenSight Biologics SA 2025 Universal Registration Document
• GenSight Biologics SA 2024 Universal Registration Document
• GenSight Biologics SA 2023 Universal Registration Document
• GenSight Biologics SA 2022 Universal Registration Document
• GenSight Biologics SA 2020 Universal Registration Document